Case Study

Bringing relief for Luka: From hospital stays to at-home infusion care

Luka - Crohn's

Luka is a child managing pediatric Crohn's disease. His care team prescribed Remicade, an infusion therapy he received at Children's Hospital of Wisconsin every few weeks. For most kids, a school day is just a school day. For Luka, treatment day meant packing an overnight bag and missing class, on top of everything else that comes with managing a chronic condition at a young age.

The challenge

Every Remicade infusion required a trip to the hospital, and every trip meant a missed day of school. The disruption, however, did not stay contained to the appointment itself. It reached into Luka's routine, his classroom time, and the rhythm of family life at home. For a young child, that kind of recurring interruption adds up fast, both for the patient and for the parents coordinating around it.

ZZuwYb022H0kagZZ MeetLuka%E2%80%94memberstory 4962%C3%972439%2C300PPI luka member card 4962x2439 1 1 image

The Leap solution

Luka's family is covered through an employer-sponsored health plan, and that is how they connected with Leap. A Leap Care Guide worked directly with Luka's family and his prescribing physician to move his infusions home. A registered nurse was assigned as Luka's dedicated infusion nurse for every visit, so the same clinician who knew his history and his routine showed up each time.

Patient impact

Since moving treatment home, Luka has had zero missed school days. He gets his infusion, then goes back to being a kid: relaxing, video chatting with friends, getting on with his day instead of losing it.

"Getting his infusions at home meant no more packing a hospital bag or missing school," Luka's parent says. "He can relax, video chat with friends, and just be a kid. It's not a big deal anymore. We get his meds, and off we go!"

krRR8g j4UIY1EcA EmployerROI%E2%80%94Memberquote%2CLukaside by side 4962%C3%972439%2C300PPI employer roi member quote luka 4962x2439 1 image

Employer impact

The same shift that gave Luka his school days back also removed a hidden cost from his employer's health plan. Hospital-administered infusion drugs are typically billed under a buy-and-bill model, where the hospital marks up the drug itself, often steeply, and bundles that markup into a single claim the employer cannot itemize. 

By coordinating Luka's Remicade infusions, Leap removed that markup at the source. The result: $6,602 in annual drug savings for his employer's health plan, with no change to Luka's coverage, his prescriber, or his plan of care.

E5noG28EYMqTRo 1 EmployerROI%E2%80%94Lukaemployerimpactalternatesplitlayout 4962%C3%972439%2C300PPI employer roi luka employer impact layout alternate 4962x2439 1 image

The patient experience drives employer outcomes

Better patient experiences and stronger employer outcomes are correlated. Patients who stay engaged with a Care Guide are more likely to complete treatment and manage their condition, and that shows up on the employer side as:

  • Claims savings
  • Steadier attendance
  • Fewer benefits questions landing on HR’s desk

Leap’s internal analysis has found that Care Guide support saves members close to three hours per treatment, which is time they would otherwise spend chasing authorizations and sitting in waiting rooms.

Check out our blog post to learn more about the value of the patient experience.

The takeaway

A missed school day and a hidden markup often come from the same root cause: where and how a specialty drug gets billed. Moving Luka's care home fixed both at once.

If your plan has members managing pediatric or chronic specialty conditions, a claims-based savings analysis can show you where the same opportunity is hiding in your own data. 

Request a savings analysis to see what it could mean for your plan.

Additional impact stories

Dave’s story is unique, but he is one of many patients who have benefitted from Leap. Check out some other patient stories by clicking either of the tiles below. 

Share this post

More insights

uGsQNuRFuKAhTzKX benefits leader a reviewing report image
Education

Your guide to J-codes in medical billing, and what they can hide

An employer’s specialty trend was running at double digits, driven largely by therapies like Ocrevus...

Read article
gr 7yJaj1xLjiPDQ inside nurseadjustingIVdripforseniorpatientathome image
Education

Want to increase member participation in a specialty medicine solution? Reducing or waiving cost share is a good start.

One employee at a self-funded employer received Gammagard infusions twice a month for a rare autoimm...

Read article
A2LILi0roy6lnpj7 task export 6 image
Education

6 specialty medicine trends for 2027 and what they mean for benefits leaders

If it feels like specialty medicine is changing faster than your benefits strategy can keep up, that...

Read article
qmQqiddpjKSpw85s HRprofessional%E2%80%94intheoffice hr professional 3 office image
Education

Healthcare point solutions: What they are and 5 questions when evaluating them

If every healthcare point solution delivered the return in its sales deck, employer health costs wou...

Read article
XC0BuEWYGds6rfBI WeInfusepartnershipbloggraphic PNG%2C4962%C3%972439%2C300PPI 1 image
News

Leap expands specialty infusion network with WeInfuse collaboration

Leap is expanding its employer specialty infusion network through a new collaboration with WeInfuse,...

Read article
mIVvKbrIeVcspajE Spring Fall couplesittingtogetherongardenbenchwithcoffee image
Insights

Infusion vs. injection: Breaking down the basics of these two specialty therapies

In 1995, there were about 30 specialty drugs on the market. Today, there are nearly 1,000, and rough...

Read article
EJGfZMLy5m1bnieu inside closeupivdripformingdropletinhospital image
Insights

Let's blow up the buy-and-bill drug model: How it works and what it costs employers

Twice a year, a member with multiple sclerosis (MS) sits down for an Ocrevus infusion. The drug is t...

Read article
aVrzVnNYClf9oxJK Leap MS image
Insights

The real cost of MS infusion therapy and how a better member experience can bring down costs

For two years, Maria drove two hours each way for her multiple sclerosis (MS) treatment. Every appoi...

Read article
Oncology biosimilars market
Education

The emerging oncology biosimilars market and how employers can prepare.

A member who starts Keytruda today will likely organize the next two years of their life around it. ...

Read article
WWqCZQJnAGmcLNW4 Summer couplesittingtogetheronporchswing image
Education

Is home infusion safe for immunoglobulin therapy? What patients should know

Whether you've just been prescribed immunoglobulin (Ig) therapy, or you've been getting it at a clin...

Read article